Bioadhesive chitosan nanoparticles: Preparation and characterization

被引:285
作者
Dudhani, Anitha R. [1 ,2 ,3 ]
Kosaraju, Shantha L. [2 ]
机构
[1] Victoria Univ, Sch Biomed & Hlth Sci, St Albans, Vic 3021, Australia
[2] CSIRO Food & Nutr Sci, Werribee, Vic 3030, Australia
[3] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharm Practice, Parkville, Vic 3052, Australia
关键词
Chitosan; Controlled release; Catechin; Nanoparticles; Tripolyphosphate; DELIVERY-SYSTEM; INTESTINAL-ABSORPTION; MUCOADHESIVE POLYMERS; ORAL DELIVERY; POLYSACCHARIDE; PEPTIDE; INSULIN; PERMEABILITY; IMPROVE; SURFACE;
D O I
10.1016/j.carbpol.2010.02.026
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Bioadhesive chitosan nanoparticles (CS NPs) were prepared for encapsulation of catechin and evaluation of their mucoadhesive potential that leads to enhanced oral bioavailability of catechin. CS NPs and catechin loaded CS NPs were obtained by ionic gelation between the CS and sodium tripolyphosphate (TPP). Particle size distribution analysis confirmed the size ranges, 110 +/- 5 nm and 130 +/- 5 nm for CS NPs and catechin loaded CS NPs, respectively. TEM indicated smooth and spherical nanoparticles. FTIR and DSC showed no significant interactions between catechin and CS after encapsulation and cross-linking. Entrapment efficiency of 90% was achieved with a weight ratio of 2:1 (CS:TPP) at pH 5.5. In vitro release of catechin from CS NPs was 32% within 2411 and exhibited 40% and 32% mucoadhesivity for catechin loaded CS NPs and CS NPs, respectively, demonstrating potential for controlled release of catechin in GIT. Crown Copyright (C) 2010 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:243 / 251
页数:9
相关论文
共 69 条
[1]   Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine [J].
Agarwal, V ;
Mishra, B .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (06) :701-709
[2]   Nanomedicines for overcoming biological barriers [J].
Alonso, MJ .
BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (03) :168-172
[3]   Polymeric carriers for oral uptake of microparticulates [J].
Andrianov, AK ;
Payne, LG .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (2-3) :155-170
[4]  
[Anonymous], 2002, J PHARM SCI, DOI DOI 10.1002/JPS.10149
[5]   EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
ARTURSSON, P ;
LINDMARK, T ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1358-1361
[6]   Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note [J].
Bhumkar, Devika R. ;
Pokharkar, Varsha B. .
AAPS PHARMSCITECH, 2006, 7 (02)
[7]   The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption .3. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro [J].
Borchard, G ;
Luessen, HL ;
deBoer, AG ;
Verhoef, JC ;
Lehr, CM ;
Junginger, HE .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :131-138
[8]  
Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
[9]  
2-4
[10]   Oral particulate delivery: status and future trends [J].
Chen, HM ;
Langer, R .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (2-3) :339-350